Aviation Medication Transparency Act of 2025

HR 2592, the Aviation Medication Transparency Act of 2025, requires the Federal Aviation Administration (FAA) to create and maintain a public website listing medications approved for use by pilots and aircrew (airmen) during medical certification. The list must be developed with input from pilots' unions, air traffic controllers' representatives, and other stakeholders, and include details like "Do Not Issue" medications, required duty limitations for new medications, and contact information for medical providers. The FAA must publish this list within one year of the bill's enactment and update it annually. This directly affects pilots seeking or holding medical certifications by providing clear, accessible information about medication use in aviation.